Skip to content

A clinical trial to study the effects of multi-modal interventions on quality of life, symptom burdens and self efficacy among ovarian cancer patients

Effectiveness of multi-modal interventions on Quality of life, symptom burdens and self-efficacy among ovarian cancer patients in a selected oncology hospital, Kolkata. - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070768
Enrollment
200
Registered
2024-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C569- Malignant neoplasm of unspecifiedovary

Interventions

Intervention1: Multi-modal interventions: Multi-modal interventions refer to four multi-component nursing interventions sessions as pre-treatment session, sensitization session, prehabilitation sessio

Sponsors

Chaitali Biswas
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed Ovarian cancer patients 1. With any stage from II, III, and IV. 2. Eastern Cooperative Oncology group (ECOG) performance status within 2. 3. Planned for initial treatment either with chemotherapy or Surgery. 4. Able to understand, read, and write Bengali or Hindi or English. 5. Who are willing to be a part of the study

Exclusion criteria

Exclusion criteria: Ovarian cancer patients who are 1. Critically ill. 2. ECOG performance status more than 2. 3. Diagnosed as a relapse of ovarian cancer patients. 4. under palliative care

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of multi-modal interventions on Quality of life, Symptom management and self-efficacy among ovarian cancer pateintsTimepoint: Quality of life, Symptom burdens, and self-efficacy as the outcome of the multi-modal intervention will be assessed at baseline, 3 month, 6 month and 9 month for both experimental arm and control arm

Secondary

MeasureTime frame
To encourage and motivate the individual Ovarian cancer patients under study to adapt the intervention in their daily life and thus to improve the self-efficacy and self management of symptoms and health related quality of lifeTimepoint: at 9 months after the study as well as continue throughout the survival period

Countries

India

Contacts

Public ContactDr Jaydip Bhaumik

Tata Medical Center

jaydip.bhaumik@tmckolkata.com919748181117

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026